Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Marsche Gunther |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Cosic-Mujkanovic, N; Valadez-Cosmes, P; Maitz, K; Lueger, A; Mihalic, ZN; Runtsch, MC; Kienzl, M; Heinemann, A; Schicho, R; Marsche, G; Kargl, J
THE ROLE OF NEUTROPHIL-DERIVED MYELOPEROXIDASE (MPO) IN NON-SMALL CELL LUNG CANCER METASTASIS
FREE RADICAL BIO MED. 2024; 218: 7-7.-Annual Meeting of the Society-for-Free-Radical-Research-Europe (SFRR-E); JUN 05-07, 2024; Istanbul, TURKEY.
Doi: 10.1016/j.freeradbiomed.2024.04.032
[Poster]
Web of Science
FullText
FullText_MUG
Pammer, A; Stadler, JT; Pferschy, PN; Tripolt, NJ; Habisch, H; Madl, T; Sourij, H; Marsche, G
Intermittent fasting and its effects on HDL function in type 2 diabetes mellitus.
31st ANNUAL MEETING of the Austrian Atherosclerosis Society; MAY 2-4, 2024; St.Gilgen am Wolfgangsee, AUSTRIA. 2024.
[Oral Communication]
Pammer, A; Stadler, JT; Pferschy, PN; Tripolt, NJ; Habisch, H; Madl, T; Sourij, H; Marsche, G
Effects of Intermittent Fasting on HDL Function in Individuals with Type 2 Diabetes Mellitus.
30th ANNUAL SCANDINAVIAN ATHEROSCLEROSIS CONFERENCE; MÄRZ 13-16, 2024; Humlebaek, DENMARK. 2024.
[Poster]
Pammer, A; Stadler, JT; Rani, A; Meissl, S; Klobučar, I; Degoricija, V; Pregartner, G; Habisch, H; Madl, T; Frank, S; Marsche, G
Measures of HDL-related Functions and Mortality in Acute Heart Failure Patients
DOC DAY ; FEB 8, 2024; Graz, AUSTRIA. 2024.
[Poster]
Stadler, JT; Bärnthaler, T; Habisch, H; Pammer, A; Borenich, A; Madl, T; Heine, GH; Christoffersen, C; Marsche, G
Low Apolipoprotein M is Associated with Incident Cardiovascular Events in Patients with Chronic Kidney Disease
AAS Annual Meeting 2024; MAY 2-4; St. Gilgen, AUSTRIA. 2024.
[Oral Communication]
FullText
Stadler, JT; Bärnthaler, T; Habisch, H; Pammer, A; Borenich, A; Madl, T; Heine, GH; Christoffersen, C; Marsche, G;
Apolipoprotein M and incident cardiovascular events in patients with chronic kidney disease
30th ANNUAL SCANDINAVIAN ATHEROSCLEROSIS CONFERENCE; MAR 13-16, 2024 ; Humlebaek, DENMARK. 2024.
[Poster]
FullText
Stauber, RE; Rainer, F; Stadlbauer, V; Avian, A; Scharnagl, H; Marsche, G
A HDL-based prognostic model performs better than MELD in chronic liver failure
J HEPATOL. 2024; 80: S383-S383.-EASL Congress; JUN 5-8, 2024; Milan, ITALY.
[Poster]
Web of Science
Mujkanovic, NC; Valadez-Cosmes, P; Maitz, K; Lueger, A; Kindler, O; Marsche, G; Kargl, J
MYELOPEROXIDASE IMPACTS LUNG CANCER CELLS AND DRIVES TUMOR PROGRESSION IN NON-SMALL CELL LUNG CANCER
FREE RADICAL BIO MED. 2023; 201: 53-53.-Annual Meeting of the Society for Free Radical Research Europe (SFRR E); JUN 06-09, 2023; Vienna, AUSTRIA.
Doi: 10.1016/j.freeradbiomed.2023.03.214
[Poster]
Web of Science
FullText
FullText_MUG
Rani, A; Baladin, D; Kienzl, M; Stadler, J; Jandl, K; Prassl, R; Marsche, G
Anti-inflammtory effects of synthetic HDL nanodiscs.
Doc Day 2023; FEB 09, 2023; Graz, Austria. 2023.
[Oral Communication]
FullText
Rani, A; Baladin, D; Kienzl, M; Stadler, J; Jandl, K; Prassl, R; Marsche, G
Anti-inflammatory effects of synthetic HDL nanodiscs.
Doctoral Day; FEB 09, 2023; Graz, Austria. 2023.
[Oral Communication]
FullText
Rani, A; Baladin, D; Kienzl, M; Stadler, J; Prassl, R; Marsche, G
Anti-inflammatory effects of synthetic HDL nanodiscs
https://bionanomed.at/. 2023; -BioNanoMed 2023; APR 12-14; Graz, Austria.
[Poster]
Rani, A; Baladin, D; Kienzl, M; Stadler, JT; Prassl, R; Marsche, G
Anti-inflammatory effects of synthetic HDl nanodiscs
Austrian Atherosclerosis Society Annual Meeting; MAY 12-13, 2023; St. Gilgen, Austria. 2023.
[Poster]
FullText
Rani, A; Baladin, D; Teppan, J; Kienzl, M; Jandl, K; Bärnthaler, T; Lanz, I; Stadler, J; Böhm, E; Prassl, R; Marsche, G
Synthetic HDL-nanodiscs as a drug-candidate in pulmonary inflammation
WIEN KLIN WOCHENSCHR. Abstracts. 2023; 135(19-20):566-566.-47. Jahrestagung der ÖGP - 7. Jahrestagung der ÖGTC; OCT 23-25, 2023; Graz, Austria.
[Poster]
Web of Science
Stadler, J; Van Poppel, M; Desoye, G; Wadsack, C; Marsche, G
OBESITY AFFECTS MATERNAL AND NEONATAL HDL METABOLISM AND FUNCTION
ATHEROSCLEROSIS. 2023; 379: S60-S60.-91st Annual Meeting of the European-Atherosclerosis-Society (EAS); MAY 21-24, 2023; Mannheim, GERMANY.
[Oral Communication]
Web of Science
Stadler, JT; Mangge, H; Habisch, H; Rani, A; Curcic, P; Hermann, M; Prüller, F; Madl, T; Marsche, G
Alterations in high-density lipoprotein-related parameters and mortality risk among hospitalized COVID 19 patients
DocDay 2023; February, 9; Graz, AUSTRIA. 2023.
[Poster]
Stadler, JT; Mangge, H; Habisch, H; Rani, A; Curcic, P; Herrmann, M; Prüller, F; Madl, T; Marsche, G
HIGH-DENSITY LIPOPROTEIN-RELATED PARAMETERS INDICATE DISEASE SEVERITY IN COVID-19 PATIENTS
30. Annual Meeting of the AAS - Austrian Atherosclerosis Society; May 12-13, 2023; St. Gilgen, AUSTRIA. 2023.
[Poster]
Madl, T; Kerbl-Knapp, J; Rainer, F; Douschan, P; Stadlbauer, V; Avian, A; Marsche, G; Claria, J; Stauber, RE
A novel metabolomics-based prognostic model shows superior diagnostic accuracy than MELD in chronic liver failure
J HEPATOL. 2022; 77: S346-S346.-EASL Annual Meeting; JUN 22-26, 2022; London, UK.
[Poster]
Web of Science
Stadler, JT; Scharnagl, H; Amtmann, B; Wadsack, C; Christoffersen, C; Marsche, G
Hypertension in pregnancy: Impact on high-density lipoprotein composition and function
28th Annual Scandinavian Atherosclerosis Conference; April 6-9, 2022; Humlebaek, DENMARK. 2022.
[Poster]
Stadler, JT; Scharnagl, H; Wadsack, C; Marsche, G
Hypertension in pregnancy: Impact on high-density lipoprotein composition and function
Doctoral Day Medical University of Graz; February 12, 2021; Graz, AUSTRIA. 2021.
[Onlinepräsentation]
Emrich, I; Trieb, M; Scharnagl, H; Pregartner, G; Holzer, M; Rogacev, K; Bohm, M; Heine, GH; Marsche, G
HDL Subclasses as a Prognosis Marker of newly occurring cardiovascular Events in chronic Kidney Disease.
INTERNIST. Abstracts zum 126. Kongress der Deutschen Gesellschaft für Innere Medizin e.V.. 2020; 61(SUPPL 1):S7-S8.-126. Kongress der Deutschen Gesellschaft für Innere Medizin e.V.; APR 25-28, 2020; Wiesbaden, GERMANY.
[Oral Communication]
Web of Science
Guettler, J; Forstner, D; Nonn, O; Maninger, S; Kupper, N; Cvirn, G; Marsche, G; Huppertz, B; Gauster, G
Maternal platelet interactions with fetal extravillous trophoblast cells.
International Cell Culture Under Flow Meeting 2020; FEB 18-19, 2020; Munich. 2020.
[Oral Communication]
FullText
Reisinger, A; Marsche, G; Eller, P
HDL-CHOLESTERIN KORRELIERT INVERS MIT DEM SOFA-SCORE IN DER SEPSIS.
Wiener Intensivmedizinische Tage WIT 2020; FEB 12-15, 2020; Vienna, Austria. 2020.
[Oral Communication]
Forstner, D; Maninger, S; Nonn, O; Guettler, J; Moser, G; Leitinger, G; Pritz, E; Schallmoser, K; Marsche, G; Heinemann, A; Cvirn, G; Huppertz, B; Gauster, M
Platelet-derived factors impair placental chorionic gonadotropin synthesis
19. Treffen des Arbeitskreises Molekularbiologie der Deutschen Gesellschaft für Gynäkologische Endokrinologie und Fortpflanzungsmedizin (DGGEF) und der Deutschen Gesellschaft für Reproduktionsmedizin (DGRM); NOV 22-23, 2019; Düsseldorf, GERMANY. 2019.
[Oral Communication]
Forstner, D; Maninger, S; Nonn, O; Guettler, J; Moser, G; Leitinger, G; Pritz, E; Schallmoser, K; Marsche, G; Heinemann, A; Huppertz, B; Gauster, M
Platelet-derived soluble factors impair placental chorionic gonadotropin synthesis
Doctoral Day 2019; NOV 21, 2019; Graz, AUSTRIA. 2019.
[Poster]
Forstner, D; Nonn, O; Guettler, J; Maninger, S; Moser, G; Leitinger, G; Pritz, E; Schallmoser, K; Siwetz, M; Marsche, G; Heinemann, A; Goeritzer, M; Hoch, D; Desoye, G; Huppertz, B; Gauster, M
Platelet derived factors impair chorionic gonadotropin Synthesis in human trophoblasts
Joint Meeting on Vascular Biology, Inflammation and Thrombosis; JUN 6-7, 2019; Vienna, AUSTRIA. 2019.
[Oral Communication]
Guettler, J; Forstner, D; Nonn, O; Maninger, S; Kupper, N; Wernitznig, S; Cvirn, G; Marsche, G; Huppertz, B; Gauster, M
Platelet activation interferes with steroid hormone synthesis of syncytiotrophoblast during first trimester of pregnancy
19. Treffen des Arbeitskreises Molekularbiologie der Deutschen Gesellschaft für Gynäkologische Endokrinologie und Fortpflanzungsmedizin (DGGEF) und der Deutschen Gesellschaft für Reproduktionsmedizin (DGRM); NOV 22-23, 2019; Duesseldorf, DEUTSCHLAND. 2019.
[Oral Communication]
Guettler, J; Forstner, D; Nonn, O; Maninger, S; Kupper, N; Wernitznig, S; Cvirn, G; Marsche, G; Huppertz, B; Gauster, M .
Platelet activation interferes with steroid hormone synthesis of syncytiotrophoblast during first trimester of pregnancy
Doctoral Day 2019 (Medical University Graz); Nov 21, 2019; Graz, AUSTRIA. 2019.
[Poster]
Guettler, J; Forstner, D; Nonn, O; Maninger, S; Kupper, N; Wernitznig, S; Goeritzer, M; Marsche, G; Huppertz, B; Gauster, M
CHARACTERIZATION OF PLATELET - TROPHOBLAST INTERACTIONS IN HUMAN FIRST TRIMESTER PLACENTA
PLACENTA. 2019; 83: E78-E79.-Meeting of the International-Federation-of-Placenta-Associations (IFPA); SEP 10-13, 2019; Buenos Aires, ARGENTINA.
Doi: 10.1016/j.placenta.2019.06.249
[Poster]
Web of Science
FullText
FullText_MUG
Guettler, J; Forstner, D; Nonn, O; Maninger, S; Kupper, N; Wernitznig, S; Goeritzer, M; Marsche, G; Huppertz, B; Gauster, M
Interaction of human platelets with placental trophoblasts
Joint Meeting on Vascular Biology, Inflammation and Thrombosis; JUN 6-7, 2019; Vienna, AUSTRIA. 2019.
[Poster]
Holzer, M; Birner-Gruenberger, R; Marsche, G
The proteome of HDL2/3 is not as complex as previously anticipated
8th IAS workshop on HDL ; SEP 25-27, 2019; Valencia, Spain. 2019.
[Poster]
Holzer, M; Marsche, G
HDL research: From the wild west to reproducibility
IAS - HDL workshop 2019: Structure, novel functions and therapeutic applications; SEP 25-27, 2019; Valencia, Spain. 2019.
[Poster]
Horvath, A; Leber, B; Feldbacher, N; Tripolt, N; Rainer, F; Blesl, A; Trieb, M; Marsche, G; Sourij, H; Stadlbauer, V
A randomized, double-blind, placebo-controlled pilot study on the effects of a multispecies synbiotic in diabesity
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S470-S470.-47. Jahrestagung der ÖDG; NOV 21-23, 2019;
[Poster]
Web of Science
Knuplez,E; Curcic, S; Sturm, E; Heinemann, A; Marsche, G.
In vitro and in vivo inhibiton of eosinophil activation by lysophosphatidylcholine and synthetic alkyl-lysophosphatidylcholine
11th Biennial Symposium of the International Eosinophil Society; JUL 9-13; Portland, USA. 2019.
[Poster]
Marsche, G
Alleric Rhinitis is associated with complex alterations in HDL composition, metabolism and function
Workshop on High Density Lipoproteins; SEP 25-27, 2019; Valencia, SPAIN. 2019.
[Oral Communication]
Marsche, G; Kornej, J; Trieb, M; Buettner, P
ATRIAL FIBRILLATION IS ASSOCIATED WITH ALTERATIONS IN HDL FUNCTION, METABOLISM AND PARTICLE NUMBER
ATHEROSCLEROSIS. 2019; 287: E55-E55.
Doi: 10.1016/j.atherosclerosis.2019.06.155
[Poster]
Web of Science
FullText
FullText_MUG
Marsche, G; Trieb, M; Büttner, P
Atrial fibrillation is associated with alterations in HDL
function, metabolism and particle number
The Cardiorenal Axis
From risk stratification to
personalized treatment; JAN 17-18, 2019; Mannheim, GERMANY. 2019.
[Poster]
Roula, D; Theiler, A; Luschnig, P; Sturm, G; Tomazic, P; Marsche, G; Heinemann, A; Sturm, E
Apolipoprotein A-IV exhibits anti-inflammatory properties in vitro and is decreased in allergic patients.
Inflammation: from initiation to restoration; APR 24-26, 2019; Edinburgh, UNITED KINGDOM. 2019.
[Poster]
FullText
Scheuer, AL; Emrich, IE; Rogacev, KS; Solovyeva, E; Scharnagl, H; Martin, SS; Fliser, D; Bohm, M; Marsche, G; Geisel, J; Heine, GH
Comparison of Low-Density Lipoprotein Estimation by using the Friedewald Formula vs. Martin/Hopkins Formula in a Cohort of chronically kidney Patients
INTERNIST. 2019; 60: S35-S35.
[Poster]
Web of Science
Scheuer, AL; Emrich, IE; Zawada, AM; Kern, S; Heinemann, A; Rogacev, KS; Fliser, D; Heine, GH; Marsche, G
Predictive Efficieny of Cholesterol Efflux Capacity for the Progression of Chronic Kidney Disease
INTERNIST. 2019; 60: S35-S35.
[Poster]
Web of Science
Stadler, JT; Meissl, S; Desoye, G; van Poppel, MNM; Marsche, G
Effects of pregnancy complications on maternal and fetal
high-density lipoprotein functionalities in the DALI trial
Doctoral Day 2019; NOV 21, 2019; Graz, Austria. 2019.
[Poster]
Sturm, E; Roula, D; Theiler, A; Luschnig, P; Sturm, GJ; Tomazic, PV; Marsche, G; Heinemann, A
Apolipoprotein A-IV is reduced in serum of allergic patients and acts as an endogenous anti-inflammatory protein
EUR RESPIR J. 2019; 54: -European-Respiratory-Society (ERS) International Congress; SEP 28-OCT 02, 2019; Madrid, SPAIN.
Doi: 10.1183/13993003.congress-2019.OA1625
[Oral Communication]
Web of Science
FullText
FullText_MUG
Trakaki, A; Sturm, GJ; Pregartner, G; Scharnagl, H; Eichmann, TO; Trieb, M; Knuplez, E; Holzer, M; Stadler, JT; Heinemann, A; Sturm, EM; Marsche, G
Role of high-density lipoprotein composition and function in allergy
DK-MOLIN Annual Retreat; APR 11-13; Schloss Seggau, Leibnitz, AUSTRIA. 2019.
[Oral Communication]
Bärnthaler, Th; Jandl, K; Sill, H; Uhl, B; Schreiber, Y;
Thomas, D; Schicho, R; Marsche, G; Frank, S; Heinemann, A; Schuligoi, R
IMATINIB AND NILOTINIB ARE STRONG STIMULATORS OF PGE2 SYNTHESIS AND ATTENUATE INFLAMMATORY CYTOKINE RELEASE VIA EP4 RECEPTOR ACTIVATION.
7th European Workshop on Lipid Mediators; SEP 12-14, 2018; Brussels, BELGIUM. 2018.
[Poster]
Buettner, P; Trieb, M; Marsche, G; Hindricks, G; Arya, A; Sommer, P; Dinov, B; Bollmann, A; Husser, D; Kornej, J
HDL-function in atrial fibrillation
CARDIOVASC RES. . 2018; 114: S79-S79.-5th Congress of the ESC-Council-on-Basic-Cardiovascular-Science on Frontiers in Cardio Vascular Biology; APR 20-22, 2018; Vienna, AUSTRIA.
Doi: 10.1093/cvr/cvy060.225
[Poster]
Web of Science
FullText
FullText_MUG
Forstner, D; Maninger, S; Nonn, O; Moser, G; Leitinger, G; Pritz, E; Schallmoser, K; Siwetz, M; Marsche, G; Heinemann, A; Hoch, D; Desoye, G; Huppertz, B; Gauster, M
Platelet-derived factors impair trophoblast Differentiation via activation of Smad3 signaling
18. Treffen des Arbeitskreises Molekularbiologie der DGGEF und DGRM; DEZ 7-8, 2018; Essen, GERMANY. 2018.
[Oral Communication]
Forstner, D; Maninger, S; Nonn, O; Moser, G; Leitinger, G; Pritz, E; Schallmoser, K; Siwetz, M; Marsche, G; Heinemann, A; Hoch, D; Desoye, G; Huppertz, B; Gauster, M
PLATELET DERIVED FACTORS IMPAIR TROPHOBLAST DIFFERENTIATION VIA ACTIVATION OF SMAD3 SIGNALING
PLACENTA. 2018; 69: E88-E88.-Meeting of the International-Federation-of-Placenta-Associations (IFPA); SEP 21-24, 2018; Tokyo, JAPAN.
[Poster]
Web of Science
Forstner, D; Maninger, S; Nonn, O; Moser, G; Leitinger, G; Pritz, E; Schallmoser, K; Siwetz, M; Marsche, G; Heinemann, A; Hoch, D; Desoye, G; Huppertz, B; Gauster, M
Influence of platelet-derived factors on villous trophoblast differentiation
8. ASEM Workshop; APR 26-27, 2018; Vienna, AUSTRIA. 2018.
[Poster]
Forstner, D; Maninger, S; Nonn, O; Moser, G; Leitinger, G; Pritz, E; Schallmoser, K; Siwetz, M; Marsche, G; Heinemann, A; Hoch, D; Desoye, G; Huppertz, B; Gauster, M;
Platelet-derived factors impair trophoblast Differentiation via activation of Smad3 signaling
Abstract Book Retrain The Brain Doctoral Day 2018. 2018; -Doctoral Day 2018; NOV 28, 2018; Graz, AUSTRIA.
[Oral Communication]
FullText
Forstner, Désirée (1); Schallmoser, Katharina (2); Siwetz, Monika (1); Maninger, Sabine (1); Nonn, Olivia (1); Marsche, Gunther (3); Heinemann, Akos (3); Hoch, Denise (4); Huppertz, Berthold (1); Gauster, Martin (1)
Organization(s): 1: Gottfried Schatz Research Center for Cell Signaling, Metabolism and Aging (Unit: Cell Biology, Histology and Embryology), Medical University of Graz; 2: University Clinic of Blood Group Serology and Transfusion Medicine, Paracelsus Medical University, Salzburg; 3: Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation (Unit: Pharmacology), Medical University of Graz; 4: Department of Obstetrics and Gynecology, Medical University of Graz
The role of adhering maternal platelets on villous trophoblast
ISC 2018; MAY 31 - JUNE 2, 2018; Graz, AUSTRIA. 2018.
[Oral Communication]
Knuplez, E; Curcic, S; Cvirn, G; Marsche, G
Role of apolipoprotein C-III on platelet activation
Doctoral Day at the Medical University of Graz; NOV 28, 2018; Graz, AUSTRIA. 2018.
[Oral Communication]
Knuplez, E; Curcic, S; Heinemann, A; Marsche, G
The anti-cancer alkylphosphocholine drug Miltefosine potently suppresses eosinophil
over-activation
“Cancer, Inflammation, Immunity” Retreat
Joint DK retreat MCBO/MOLIN/IAI; JAN 13-17, 2018; Obergurgl, AUSTRIA. 2018.
[Poster]
Knuplez, E; Curcic, S; Heinemann, A; Marsche, G
The anti-cancer alkylphosphocholine drug Miltefosine potently suppresses eosinophil over-activation
DK Molin Annual Retreat 2018; APR 11-13, 2018; Schloss Seggau, Austria. 2018.
[Oral Communication]
Knuplez, E; Curcic, S; Sturm, EM; Heinemann, A; Marsche, G
The anti-cancer alkylphosphocholine drug Miltefosine potently suppresses eosinophil over-activation
24th Scientific Symposium of the Austrian Pharmacological Society (APHAR); SEP 27-28, 2018; Graz, AUSTRIA. 2018.
[Oral Communication]
Knuplez, E; Curcic, S; Sturm, EM; Heinemann, A; Marsche, G
Lysophosphatidylcholine and its synthetic analogue miltefosine potently suppress eosinophil over-activation
WISC 2018- Personalized medicine in allergy: Biologics & Immunotherapy; DEC 05-09, 2018; Florence, ITALY. 2018.
[Poster]
Knuplez, E; Sturm, EM; Heinemann, A; Marsche, G
Lysophosphatidylcholine and its synthetic analogue Miltefosine potently suppress eosinophil over-activation
59th International Conference on the Bioscience of Lipids: ’Lipid Fluxes and Metabolism – From Fundamental Mechanisms to Human Disease’; SEP 4-7, 2018; Helsinki, FINLAND. 2018.
[Poster]
Roula, D; Theiler, A; Luschnig, P; Sturm, G; Tomazic, P; Marsche, G; Heinemann, A; Sturm, E
Apolipoprotein A-IV potently suppresses eosinophil responsiveness in vitro and alleviates house dust mite-induced airway hyperreactivity in mice
Doctoral Day of the Medical University of Graz; NOV 28, 2018; Graz, AUSTRIA. 2018.
[Oral Communication]
FullText
Roula, D; Theiler, A; Luschnig, P; Sturm, GJ, Marsche, G, Heinemann, A; Sturm, EM
Apolipoprotein A-IV potently suppresses eosinophil responsiveness in vitro and alleviates house dust mite-induced airway hyperreactivity in mice
Intrinsic Activity, 2018; 6 (Suppl. 1) . 2018; -24th Scientific Symposium of the Austrian Pharmacological Society (APHAR) ; SEPT 27 – 28, 2018 ; Graz, AUSTRIA.
[Oral Communication]
FullText
Trakaki, A; Sturm, E; Sturm, G; Meissl, S; Heinemann, A; Marsche, G
Role of High-Density Lipoprotein (HDL) Composition and Function in Allergy
DK-MOLIN Annual Retreat; APR 11-13; Schloss Seggau, AUSTRIA. 2018.
[Oral Communication]
Trakaki, A; Sturm, E; Sturm, GJ; Heinemann, A; Marsche, G
Allergic rhinitis is associated with complex alterations in high-density lipoprotein composition and function
Joint Doctoral Retreat on Immunity in Infection & Allergy 2018; NOV 29-DEC 03, 2018; Obergurgl, Austria. 2018.
[Oral Communication]
Trakaki, A; Sturm, E; Sturm, GJ; Heinemann, A; Marsche, G
Role of high-density lipoprotein, composition and function in allergy
Retrain The Brain Doctoral Day 2018; NOV 28, 2018; Graz, Austria. 2018.
[Poster]
Trakaki, A; Sturm, E; Sturm, GJ; Heinemann, A; Marsche, G
Allergic rhinitis is associated with complex alterations in high-density lipoprotein composition and function
WAO International Scientific Conference WISC 2018; DEC 06-09, 2018; Florence, Italy. 2018.
[Poster]
Voortman, M; Pichler, A; Enzinger, C; Fuchs, S; Bachmaier, G; Archelos-Garcia, JJ; Fazekas, F; Marsche, G; Khalil, M
Decreased cerebrospinal fluid antioxidative capacity is associated with disease severity and progression in early Multiple Sclerosis (MS)
EUR J NEUROL. 2018; 25: 434-434.-4th Congress of the European-Academy-of-Neurology (EAN); JUN 16-19, 2018; Lisbon, PORTUGAL.
[Oral Communication]
Web of Science
Voortman, MM; Pichler, A; Enzinger, C; Fuchs, S; Bachmaier, G; Archelos, J-J; Fazekas, F; Marsche, G; Khalil, M
Decreased cerebrospinal fluid antioxidative capacity is associated with disease severity and progression in early multiple sclerosis.
Abstract book 2nd Meeting of the Society for CSF analysis and clinical neurochemistry. 2018; 73-73.-2nd Meeting of the Society for CSF analysis and clinical neurochemistry; JUN 7-8, 2018; Amsterdam, THE NETHERLANDS.
[Poster]
FullText
Voortman, MM; Pichler, A; Enzinger, C; Fuchs, S; Bachmaier, G; Archelos, JJ; Fazekas; Marsche, G; Khalil, M
Decreased cerebrospinal fluid antioxidative capacity is associated with disease severity and progression in early multiple sclerosis.
Neurologisch. 2018; 2018(S1):61-61.-15. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); MAR 21-23, 2018; Linz, AUSTRIA.
[Poster]
FullText
Curcic, S; Holzer, M; Pasterk, L; Knuplez, E; Eichmann, TO; Frank, S; Zimmermann, R; Schicho, R; Heinemann, A; Marsche, G
Lysophospholipid-enriched HDL suppresses platelet activation
23rd Scientific Symposium of the Austrian Pharmacological Society (APHAR) ; SEP 28-29, 2017; Innsbruck, AUSTRIA. 2017.
[Poster]
Curcic, S; Holzer, M; Pasterk, L; Knuplez, E; Eichmann, TO; Frank, S; Zimmermann, R; Schicho, R; Heinemann, A; Marsche, G.
Secretory phospholipase A2 modified HDL potently inhibits platelet activation
9th ÖGMBT Annual Meeting; SEP 25-27, 2017; Innsbruck, AUSTRIA. 2017.
[Poster]
Forstner, D; Schallmoser, K; Siwetz, M; Maninger, S; Marsche, G; Curcic, S; Gauster, M
EINFLUSS VON THROMBOZYTENFAKTOREN AUF DEN VILLÖSEN TROPHOBLASTEN
Journal für Reproduktionsmedizin und Endokrinologie. 2017; -Gemeinsame Jahrestagung der Österreichischen Gesellschaft für Reproduktionsmedizin und Endokrinologie und der Österreichischen IVF-Gesellschaft; SEP 28-30, 2017; Seggau, AUSTRIA.
[Oral Communication]
Forstner, D; Schallmoser, K; Siwetz, M; Maninger, S; Marsche, G; Heinemann, A; Hoch, D; Huppertz, B; Gauster, M
INFLUENCE OF PLATELET-DERIVED FACTORS ON THE VILLOUS TROPHOBLAST
Abstractbook Interdisciplinary Autumn School for Reproductive Sciences and related Research Fields 2017. 2017; -Interdisciplinary Autumn School for Reproductive Sciences and related Research Fields; OCT 18-21, 2017; Magdeburg, GERMANY.
[Oral Communication]
Forstner, D; Schallmoser, K; Siwetz, M; Maninger, S; Marsche, G; Heinemann, A; Hoch, D; Huppertz, B; Gauster, M
Influence of platelet-derived factors on the villous trophoblast
Abstractbook DocDay 2017. 2017; -Doctoral Day 2017; DEC 13, 2017; Graz, AUSTRIA.
[Poster]
Irene Schilcher, Gerhard Ledinski, Seth Hallström, Tobias Madl, Thomas O. Eichmann, Gerd Leitinger, Dagmar Kolb-Lenz, Ruth Birner-Gruenberger, Gunther Marsche and Saša Frank
Endothelial Lipase Augments Antioxidative Capacity of HDL
ELC (European Lipoprotein Club); SEPT 4-7, 2017; Tutzing, GERMANY. 2017.
[Poster]
Knuplez, E; Curcic, S; Heinemann, A; Marsche, G
The anti-cancer alkylphosphocholine drug Miltefosine potently suppresses eosinophil
over-activation
Doctoral Day at the Medical University of Graz; DEC 13, 2017; Graz, AUSTRIA. 2017.
[Oral Communication]
Knuplez, E; Curcic, S; Heinemann, A; Marsche, G
The role of (secretory) phospholipases in eosinophil function.
DK Molin Annual Retreat; JAN 30 - FEB 1, 2017; Schloss Seggau, AUSTRIA. 2017.
[Oral Communication]
Knuplez, E; Curcic, S; Heinemann, A; Marsche, G
The role of lysophosphatidylcholine in eosinophil activation
23nd Scientific Symposium of the Austrian Pharmacological Society (APHAR) ; SEP 28-29, 2017; Innsbruck, AUSTRIA. 2017.
[Poster]
Knuplez, E; Curcic, S; Heinemann, A; Marsche, G
Lysophosphatidylcholine suppresses eosinophil activation
9th ÖGMBT Annual Meeting & 8th Life Sciences Meeting Innsbruck; SEP 25-26, 2017; Innsbruck, AUSTRIA. 2017.
[Poster]
Marsche, G
High density lipoproteins function in CKD
Biomarker der kardiorenalen Achse 20 Jahre LURIC und 4D; JAN 19-20, 2017; Mannheim, GERMANY. 2017.
[Poster]
Marsche, G; Holzer, M; Curcic, S
SECRETORY PHOSPHOLIPASE A2 MODIFIED HIGH-DENSITY LIPOPROTEIN POTENTLY SUPPRESSES PLATELET ACTIVATION
ATHEROSCLEROSIS. 2017; 263: E94-E94.-85th Congress of the European-Atherosclerosis-Society (EAS); APR 23-26, 2017; Prague, CZECH REPUBLIC.
Doi: 10.1016/j.atherosclerosis.2017.06.306
[Oral Communication]
Web of Science
FullText
FullText_MUG
Schilcher, I; Kern, S; Eichmann, T; Hrzenjak, A; Marsche, G; Frank, S
Impact of Endothelial Lipase Overexpression on Cholesterol Efflux Capacity of Serum and HDL
Austrian Atherosclerosis Society ; MAY 12-13, 2017; St. Gilgen am Wolfgangsee. 2017.
[Oral Communication]
Schilcher, I; Kern, S; Madl, T; Eichmann, T; Ledinski, G; Hallstrom, S; Marsche, G; Frank, S
EL-HDL EXHIBITS INCREASED CAPACITY TO ATTENUATE LDL OXIDATION INDEPENDENT OF PON1
ATHEROSCLEROSIS. 2017; 263: E216-E216.-85th Congress of the European-Atherosclerosis-Society (EAS); APR 23-26, 2017; Prague, CZECH REPUBLIC.
Doi: 10.1016/j.atherosclerosis.2017.06.703
[Poster]
Web of Science
FullText
FullText_MUG
Schilcher, I; Ledinski, G; Hallström, S; Eichmann, T; Leitinger, G; Kolb-Lenz, D; Birner-Gruenberger, R; Marsche, G; Frank, S
EL-HDL EXHIBITS INCREASED CAPACITY TO ATTENUATE LDL OXIDATION INDEPENDENT OF PON1
European Atherosclerosis Society; APR 23-26, 2017; Prague. 2017.
[Poster]
Schilcher, I; Ledinski, G; Hallström, S; Eichmann, T; Leitinger, G; Kolb-Lenz,D; Birner-Gruenberger, R; Marsche, G; Frank, S
EL-HDL exhibits increased capacity to attenuate LDL oxidation independent of PON1
Austrian Atherosclerosis Society; MAY 12-13, 2017; St. Gilgen am Wolfgangsee. 2017.
[Oral Communication]
Thomas Bärnthaler, Katharina Jandl, Rudolf Schicho, Barbara Uhl, Florian Reichmann, Magdalena Grill, Gunther Marsche, Heinz Sill, Akos Heinemann, Rufina Schuligoi
Imatinib inhibits TNFα via PGE2 and the EP4 receptor
23rd Scientific Symposium of
the Austrian Pharmacological Society APHAR; Sept 28-29, 2017; Insbruck, Austria. 2017.
[Poster]
Thomas Bärnthaler, Katharina Jandl, Rudolf Schicho, Barbara Uhl, Florian Reichmann, Magdalena Grill, Gunther Marsche, Heinz Sill, Akos Heinemann,Rufina Schuligoi
Imatinib inhibits TNF-alpha expression via PGE2 and the EP4 receptor
ÖGMBT Annual Meeting 2017, Molecular and cellular mechanisms of human diseases; Sept 25-27, 2017; Innsbruck, Austria. 2017.
[Poster]
Thomas Bärnthaler, Katharina Jandl, Rudolf Schicho, Barbara Uhl, Florian Reichmann, Magdalena Grill, Gunther Marsche, Heinz Sill, Akos Heinemann,Rufina Schuligoi
Imatinib inhibits TNF-alpha expression via PGE2 and the EP4 receptor
Doctoral Day of the Medical University of Graz 2017; Dec 13, 2017; Graz, Austria. 2017.
[Poster]
Trakaki, A; Sturm, E; Sturm, G; Meissl, S; Heinemann, A; Marsche, G
Effects of Allergy on High Density Lipoprotein (HDL) Composition and Function
Doctoral Day at the Medical University of Graz; DEC 13, 2017; Graz, AUSTRIA. 2017.
[Poster]
Trakaki, A; Sturm, E; Sturm, G; Meissl, S; Heinemann, A; Marsche, G
Role of High Density Lipoprotein (HDL), Composition and Function in Allergy
DK-MOLIN Annual Retreat; JAN-FEB 30-1, 2017; Schloss Seggau, AUSTRIA. 2017.
[Oral Communication]
Trakaki, A; Sturm, E; Sturm, G; Meissl, S; Heinemann, A; Marsche, G
Effects of Allergy on High Density Lipoprotein (HDL) Composition and Function
9th ÖGMBT Annual Meeting 2017 & 8th Life Science Meeting Innsbruck Molecular and Cellular Mechanisms of Human Diseases; SEP 25-27, 2017; Innsbruck, AUSTRIA. 2017.
[Poster]
Trakaki, A; Sturm, E; Sturm, G; Meissl, S; Heinemann, A; Marsche, G
Role of High Density Lipoprotein (HDL), Composition and Function in Allergy
23nd Scientific Symposium of the Austrian Pharmacological Society (APHAR); SEP 28–29, 2017; Innsbruck, AUSTRIA. 2017.
[Poster]
Trieb, M; Büttner, P; Kornej, J; Holzer, M; Husser, D; Marsche, G
High-density lipoprotein subclass distribution and function are profoundly altered in atrial fibrillation
Cardioflame; NOV 23, 2017; Graz, AUSTRIA. 2017.
[Poster]
Voortman, MM; Pichler, A; Enzinger, C; Fuchs, S; Bachmaier, G; Archelos, JJ; Fazekas, F; Marsche, G; Khalil, M
Decreased cerebrospinal fluid antioxidative capacity is associated with disease severity and progression in early multiple sclerosis.
Multiple Sclerosis Journal. 2017; 23(S3):303-304.-7th Joint ECTRIMS-ACTRIMS (European-Americas Committee for Treatment and Research of Multiple Sclerosis) Meeting; OCT 25-28, 2017; Paris, FRANCE.
[Poster]
Web of Science
FullText
Voortman, MM; Pichler, A; Enzinger, C; Fuchs, S; Bachmaier, G; Archelos, JJ; Fazekas, F; Marsche, G; Khalil, M
Decreased cerebrospinal fluid antioxidative capacity is associated with disease severity and progression in early multiple sclerosis.
Doctoral day of the Medical University of Graz; DEC 13, 2017; Graz, AUSTRIA. 2017.
[Oral Communication]
Curcic, S; Holzer, M; Pasterk, L; Heinemann, A; Marsche, G
Secretory phospholipase A2 modified HDL suppresses platelet activation and platelet-leukocyte crosstalk
22nd Scientific Symposium of the Austrian Pharmacological Society (APHAR); SEP 8-10, 2016; Vienna, AUSTRIA. 2016.
[Poster]
Kober, A; Chirackal Manavalan, AP; Fanaee Danesh, E; Zandl, M; Tam-Ammersdorfer, C; Albrecher, N; Marsche, G; Holzer, M; Kostner, G; Holmer, A; Dahlbäck, B; Panzenboeck, U
ATP-BINDING CASSETTE TRANSPORTER A1 AND APOLIPOPROTEIN M ARE "NOVEL PLAYERS" IN CHOLESTEROL TRANSPORT AT THE BLOOD-BRAIN BARRIER.
Proceedings of the 2016 Alzheimer's Disease Congress. 2016; -THE 2016 ALZHEIMER’S DISEASE CONGRESS; JUN 7-9,2016; London, UK.
[Poster]
Marsche, G; Heinemann, A; Pasterk, L
PLASMA ADVANCED OXIDIZED PROTEIN PRODUCTS PROMOTE PLATELET-ENDOTHELIAL CROSSTALK AND ENDOTHELIAL TISSUE FACTOR EXPRESSION
ATHEROSCLEROSIS. 2016; 252: E23-E24.-Congress of the European-Atherosclerosis-Society (EAS); MAY 29-JUN 01, 2016; Innsbruck, AUSTRIA.
Doi: 10.1016/j.atherosclerosis.2016.07.308
[Oral Communication]
Web of Science
FullText
FullText_MUG
Pasterk, L; Lemesch, S; Leber, B; Trieb, M; Curcic, S; Stadlbauer, V; Schuligo, R; Schicho, R; Heinemann, A; Marsche, G
Plasma Advanced-Oxidized Protein Products Promote Platelet-Endothelial Crosstalk and Endothelial Tissue Factor Expression
Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) Scientific Sessions; MAY 5-7,2016; Nashville, USA. 2016.
[Poster]
Pasterk, L; Lemesch, S; Leber, B; Trieb, M; Curcic, S; Stadlbauer, V; Schuligo, R; Schicho, R; Heinemann, A; Marsche, G;
The role of Plasma advanced-oxidized protein products on platelets and platelet-endothelial interactions
22nd Scientific Symposium of the Austrian Pharmacological Society (APHAR); SEP 8-10, 2016; Vienna, Austria. 2016.
[Poster]
Pasterk,L; Lemesch,S; Stadlbauer,V; Heinemann, A; Marsche, G
Oxidized plasma albumin promotes platelet-endothelial crosstalk and tissue factor expression
EAS 2016; MAY 29 - JUN 1; Insbruck, AUSTRIA. 2016.
[Poster]
Potocnjak, I; Degoricija, V; Trbusic, M; Dokoza Teresak, S; Radulovic, B; Pregartner, G; Berghold, A; Tiran, B; Marsche, G; frank, S
Metrics of high-density lipoprotein function and hospital mortality in acute heart failure patients
European Atherosclerosis Society Congress; MAY 29 - June 1; Innsbruck, AUSTRIA. 2016.
[Poster]
Potocnjak, I; Degoricija, V; Trbusic, M; Teresak, SD; Radulovic, B; Pregartner, G; Berghold, A.; Tiran, B; Marsche, G; Frank, S
LIPOPROTEINS AND LIPID METABOLISM: HDL. METRICS OF HIGH-DENSITY LIPOPROTEIN FUNCTION AND HOSPITAL MORTALITY IN ACUTE HEART FAILURE PATIENTS
ATHEROSCLEROSIS. 2016; 252: E109-E110.-Congress of the European-Atherosclerosis-Society (EAS); MAY 29-JUN 01, 2016; Innsbruck, AUSTRIA.
Doi: 10.1016/j.atherosclerosis.2016.07.602
[Poster]
Web of Science
FullText
FullText_MUG
Radnai, B; Sturm, E; Jačan, A; Jandl, K; Labocha, S; Ferreirós, N; Grill, M; Hasenoehrl, C; Gorkiewicz, G; Marsche, G; Heinemann, A; Högenauer, C; Schicho, R
Blocking Chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) is protective in experimental Crohn's disease -
proinflammatory role of eosinophils.
Bokemia, August. 2016; 3: 59-60.-Annual Conference of the Hungarian Biochemical Society; AUG 28-31, 2016; Szeged, HUNGARY.
[Poster]
FullText
Schilcher, I; Hrzenjak, A; Eichmann, T; Stojakovic, T; Scharnagl, H; Marsche, G; Frank, S
Impact of endothelial lipase overexpression on cholesterol efflux capacity of serum, apolipoproteinB- depleted serum and HDL
European Atherosclerosis Society Congress; MAY 29 - June 1; Innsbruck, AUSTRIA. 2016.
[Poster]
Schilcher, I; Hrzenjak, A; Eichmann, T; Stojakovic, T; Scharnagl, H; Marsche, G; Frank, S
IMPACT OF ENDOTHELIAL LIPASE OVEREXPRESSION ON CHOLESTEROL EFFLUX CAPACITY OF SERUM, APOLIPOPROTEIN B-DEPLETED SERUM AND HDL
ATHEROSCLEROSIS. 2016; 252: E207-E207.-Congress of the European-Atherosclerosis-Society (EAS); MAY 29-JUN 01, 2016; Innsbruck, AUSTRIA.
Doi: 10.1016/j.atherosclerosis.2016.07.140
[Poster]
Web of Science
FullText
FullText_MUG
Schilcher, I; Kern, S; Hrzenjak, A; Eichmann, T; Stojakovic, T; Scharnagl, H; Marsche, G; Frank, S
Impact of Endothelial Lipase overexpression on cholesterol efflux capacity of serum and apolipoprotein B-depleted serum as well as HDL
European Lipoprotein Club; SEPT 5-8, 2016; Tutzing, Germany. 2016.
[Poster]
Schilcher, I; Kirsch, A; Kern, S; Hrzenjak, A; Eichmann, T; Marsche, G; Frank, S
Endothelial Lipase modulates HDL-associated Paraoxonase 1 content and activity
European Lipoprotein Club; SEPT 5-8, 2016; Tutzing, Germany. 2016.
[Poster]
Schilcher, I; Kirsch, A; Kern, S; Hrzenjak, A; Marsche, G; Frank, S
Impact of Endothelial Lipase overexpression on HDL associated Paraoxonase 1 content and activity
ÖGMPT; SEPT 12-14, 2016; Graz, Austria. 2016.
[Poster]
Sturm, EM; Frei, RB; Marsche, G; Heinemann, A
Apolipoprotein A-IV negatively regulates eosinophil trafficking
ALLERGY. 2016; 71: 124-124.-Meeting of the European-Academy-of-Allergy-and-Clinical-Immunology; JUN 11-15, 2016; Vienna, AUSTRIA.
[Poster]
Web of Science
Thomas Bärnthaler, Katharina Jandl, Rudolf Schicho, Barbara Uhl, Florian Reichmann, Magdalena Grill, Gunther Marsche, Heinz Sill, Akos Heinemann,Rufina Schuligoi
Imatinib inhibits TNF-alpha expression via PGE2 and the EP4 receptor
22nd Scientific Symposium of the Austrian Pharmacological Society Joint meeting with the Hungarian Society for Experimental and Clinical Pharmacology ; Dec 8-10, 2016; Vienna, Austria. 2016.
[Poster]
Thomas Bärnthaler, Katharina Jandl, Rudolf Schicho, Barbara Uhl, Florian Reichmann, Magdalena Grill,Gunther Marsche, Heinz Sill, Akos Heinemann,Rufina Schuligoi
Imatinib inhibits TNF-alpha expression via PGE2 and the EP4 receptor
Doctoral Day of the Medical University of Graz; Dec 14, 2016; Graz Austria. 2016.
[Poster]
Trieb, M; Horvath, A; Birner-Gruenberger, R; Stadlbauer, V; Pasterk, L; Heinemann, A; Marsche, G
HDL Functionality And Liver Disease Mortality – A Causal Role For HDL In Cirrhosis?
22nd Scientific Symposium of the Austrian Pharmacological Society (APHAR); SEP 8-10, 2016; Vienna, AUSTRIA. 2016.
[Poster]
Trieb, M; Horvath, A; Stadlbauer, V; Holzer, M; Marsche, G
Liver disease alters HDL composition and function
EAS Congress 2016; MAY 29 - JUN 1; Insbruck, AUSTRIA. 2016.
[Poster]
Trieb, M; Horvath, A; Stadlbauer, V; Taschler, U; Curcic, S; Holzer, M; Pasterk, L; Heinemann, A; Marsche, G
Liver Disease Alters HDL Composition, Metabolism and Function
Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) Scientific Sessions; MAY 5-7, 2016; Nashville, USA. 2016.
[Poster]
Trieb, M; Stadlbauer, V; Birner-Gruenberger, R; Marsche, G
LIVER DISEASE ALTERS HIGH-DENSITY LIPOPROTEIN COMPOSITION, METABOLISM AND FUNCTION
ATHEROSCLEROSIS. 2016; 252: E225-E225.-Congress of the European-Atherosclerosis-Society (EAS); MAY 29-JUN 01, 2016; Innsbruck, AUSTRIA.
Doi: 10.1016/j.atherosclerosis.2016.07.199
[Oral Communication]
Web of Science
FullText
FullText_MUG
Appierto, M; Trieb, M; Pasterk, L; curcis, S; Holzer, M; Frank, S; Marsche, G
Maturation of HDL is impaired in cardiovascular disease
International Student Congress 2015; JUN 4-6, 2015; Graz, AUSTRIA. 2015.
[Oral Communication]
Appierto,M;Trieb, M;Pasterk, L; Curcic, S; Holzer, M; Frank, S; Marsche, G;
Maturation of HDL is impaired in cardiovascular disease
AAS meeting 2015; MAY 8-9 , 2015; St. Gilgen. 2015.
[Oral Communication]
Curcic, S; Holzer, M; Frei, R; Pasterk, L; Heinemann, A; Marsche, G
Neutrophil effector responses are fully suppressed by secretory phospholipase A2-modified HDL
21st Scientific Symposium of the Austrian Pharmacological Society (APHAR)
; SEP 16-18, 2015; Graz, AUSTRIA. 2015.
[Poster]
Curcic, S; Holzer, M; Frei, R; Pasterk, L; Heinemann, A; Marsche, G
Secretory phospholipase A2 shows potent anti-inflammatory effects on neutrophils
22nd Annual Meeting of the Austrian Atherosclerosis Society (AAS); MAY 8-9, 2015; St. Gilgen/Wolfgangsee, AUSTRIA. 2015.
[Oral Communication]
Leopold, C; Sachdev, V; Rainer, S; Bauer, R; Marsche, G; Scheicher, B; Hoefler, G; Kratky, D;
Consequences of acyl-CoA:diacylglycerol acyltransferase 1 deficiency on cholesterol metabolism
38th European Lipoprotein Club meeting (ECL); SEP 7-10, 2015; Tutzing, GERMANY. 2015.
[Poster]
Leopold, C; Sachdev, V; Rainer, S; Bauer, R; Marsche, G; Scheicher, B; Höfler G; Kratky, D;
Consequences of an altered cholesterol homeostasis on acyl-CoA:diacylglycerol acyltransferase 1 - deficient mice.
22nd annual meeting of the Austrian Artherosclerosis Society; MAY 8-9,2015; St.Gilgen/Wolfgangsee, AUSTRIA. 2015.
[Oral Communication]
Marsche, G; Heinemann, A; Curcic, S
NEUTROPHIL EFFECTOR RESPONSES ARE SUPPRESSED BY SECRETORY PHOSPHOLIPASE A(2) MODIFIED HDL
ATHEROSCLEROSIS. 2015; 241(1):E90-E90.-83rd Congress of the European-Atherosclerosis-Society (EAS); MAR 22-25, 2015; Glasgow, SCOTLAND.
Doi: 10.1016/j.atherosclerosis.2015.04.316
[Poster]
Web of Science
FullText
FullText_MUG
Marsche, G; Schilcher, G; Rosenkranz, A; Holzer, M
Uremia alters HDL metabolism, composition and function
ISBN: 978-3-200-04352-7. 2015; -Biomarkers in Human Health and Disease; OKT 9-10,2015; Graz.
[Oral Communication]
Marsche, G; Schilcher, G; Scharnagl, H; Stojakovic, T; Rosenkranz, A; Holzer M
Dialysis modalities, HDL metabolism and function
Symposium- Biomarker und Nierenerkrankungen ; JAN 16-17, 2015; Mannheim, GERMANY, 2014. 2015.
[Poster]
Pasterk, L; Lemesch, S; Leber, B; Trieb, M; Curcic, S; Stadlbauer, V; Schuligoi, R; Schicho,R; Heinemann, A; Marsche,G
Plasma advanced-oxidized protein products promote platelet-endothelial crosstalk and endothelial tissue factor expression
Mini-Symposium "The immune system in kidney and liver disease"; APR 21, 2015; Graz, AUSTRIA. 2015.
[Oral Communication]
Pasterk, L; Lemesch, S; Leber, B; Trieb, M; Curcic, S; Stadlbauer, V; Schuligoi, R; Schicho,R; Heinemann, A; Marsche,G,
Plasma advanced-oxidized protein products promote platelet-endothelial crosstalk and endothelial tissue factor expression
INFLAME - Symposium on Inflammation & Immunology; SEP 13-15, 2015; Graz, AUSTRIA. 2015.
[Oral Communication]
Pasterk, L; Lemesch, S; Trieb, M; Curcic, S; Appierto, M; Stadlbauer, V; Schuligoi, R; Heinemann, A; Marsche, G
Advanced-oxidized protein products activate platelets through CD36, promoting platelet-endothelial crosstalk and tissue factor expression
AAS meeting ; MAI 8-9, 2015; St. Gilgen, AUSTRIA. 2015.
[Poster]
Taschler, U; Eichmann, TO; Radner, FP; Grabner, GF; Wolinski, H; Storr, M; Lass, A; Marsche, G; Heinemann, A; Schicho, R; Zimmermann, R;
Monoglyceride lipase-deficiency causes desensitization of intestinal cannabinoid receptors and increased colonic opioid sensitivity.
21th Scientific Symposium of the Austrian Pharmacological Society (APHAR)
Joint Meeting with the British Pharmacological Society and the
Pharmacological Societies of Croatia, Serbia and Slovenia; 16–18 September, 2015; Graz, AUSTRIA. 2015.
[Oral Communication]
Trieb, M; Horvath, A; Spindelböck, W; Stadlbauer, V; Stauber, R; Holzer, M; Pasterk, L; Taschler, U; Heinemann, A; Marsche, G
Cirrhosis alters HDL metabolism and function
INFLAME - Symposium on Inflammation & Immunology; SEP 13-15, 2015; Graz. 2015.
[Poster]
Trieb, M; Horvath, A; Spindelböck, W; Stadlbauer, V; Stauber, RE; Holzer, M; Pasterk, L; Heinemann, A; Marsche, G
Metrics of HDL functions are markedly impaired in cirrhosis
22nd Annual Meeting of the Austrian Atherosclerosis Society (AAS); MAY 8-9, 2015; St. Gilgen/Wolfgangsee, AUSTRIA. 2015.
[Oral Communication]
Trieb, M; Horvath, A; Spindelböck, W; Stadlbauer, V; Stauber, RE; Pasterk, L; Holzer, M; Marsche, G
Liver cirrhosis, high–density lipoproteins and anti-inflammatory and endothelial regenerative activities of serum
Mini-Symposium "The immune system in kidney and liver disease"; APR 21, 2015; Graz, AUSTRIA. 2015.
[Oral Communication]
Appierto, M; Trieb, M; Pasterk, L; Ćurčić, S; Holzer, M;Frank, S; Marsche, G
Maturation of HDL is impaired in cardiovascular disease.
Doctoral Day 2014; DEC 10, 2014; Graz, AUSTRIA. 2014.
[Oral Communication]
Appierto, M; Trieb, M; Pasterk, L; Ćurčić, S; Holzer, M;Frank, S; Marsche, G.
HDL, inflammation and cardiovascular disease
DK-MOLIN Retreat ; OKT 29-30 , 2014; Seggau, AUSTRIA. 2014.
[Oral Communication]
Curcic, S; Holzer, M; Frei, R; Pasterk, L; Heinemann, A; Marsche, G
Secretory phospholipase A2 modified HDL fully suppresses neutrophil effector responses: Central role of palmitoyl-lysophosphatydilcholine.
Doctoral Day 2014; DEZ 10, 2014; Graz, AUSTRIA. 2014.
[Poster]
Frank, S; Opresnik, S; Rao, SP; Hrzenjak, A; Hallstrom, S; Kozina, A; Sreckovic, I; Wadsack, CH; Holzer, M; Marsche, G; Birner-Gruenberger, R; Stojakovic, T; Scharnagl, H
ENDOTHELIAL LIPASE ATTENUATES VASORELAXING CAPACITY OF HDL
ATHEROSCLEROSIS. 2014; 235(2): E45-E45.
Doi: 10.1016/j.atherosclerosis.2014.05.102
[Poster]
Web of Science
FullText
FullText_MUG
Holzer, M; Schilcher, G; Trieb, M; Curcic, S; Rosenkranz, A; Marsche, G
Hemodialysis and peritoneal dialysis differentially affect HDL composition and function
Symposium on Cardiac and Vascular Stiffness; SEP 26-27, 2014; Seggau, AUSTRIA. 2014.
[Poster]
Holzer, M; Schilcher, M; Trieb, M; Curcic, S; Rosenkranz, A; Marsche, G
Peritoneal dialysis and hemodialysis differentially modulate HDL composition and function
7th IAS Workshop on HDL - Abstract Book. 2014; -7th IAS Workshop on HDL; MAR 24-26, 2014; Rom, Italy.
[Poster]
Kopecky, C; Holzer, M; Birner-Gruenberger, R; Marsche, G; Saemann, M
Molecular Composition and Function of High-Density Lipoprotein Is Uniquely Altered After Kidney Transplantation.
AM J TRANSPLANT. 2014; 14: 565-565.-World Transplant Congress; JUL 26-31, 2014; San Francisco, CA.
[Poster]
Web of Science
Kopecky, C; Holzer, M; Birner-Gruenberger, R; Marsche, G; Saemann, M;
Molecular Composition and Function of High-Density Lipoprotein Is Uniquely Altered After Kidney Transplantation..
TRANSPLANTATION. 2014; 98: 565-565.-World Transplant Congress; JUL 26-31, 2014; San Francisco, CA.
Doi: 10.1097/00007890-201407151-01897
[Poster]
Web of Science
FullText
FullText_MUG
Kopecky, M; Haidinger, M; Birner-Grünberger, R; Kaltenecker, C; Marsche, G; Holzer, M; Saemann, MD
The molecular composition and function of HDL is uniquely altered after kidney transplantation
7th IAS Workshop on HDL - Abstract Book. 2014; -7th IAS Workshop on HDL - Abstract Book; MAR 24-26, 2014; Rom, Italy.
[Poster]
Kozina, A; Opresnik, S; Rao, S.P; Hrzenjak, A; Hallström, S; Sreckovic, I; Wadsack, Ch; Holzer, M; Marsche, G; Birner-Gruenberger, R; Stojakovic, T; Scharnagl, H; Frank, S
Endothelial lipase attenuates vasorelaxing capacity of HDL
Book of Abstracts. 2014; -21st Annual Meeting of the Austrian Atherosclerosis Society; May 9-10, 2014; St. Gilgen/ Wolfgangsee.
[Oral Communication]
Lemesch , S; Leber, B; Ribitsch, W; Schilcher, G; Horvath, A; Hafner-Gießauf, H; Spindelboeck, W; Pasterk, L; Marsche, G; Zettel, G; Tawdrous, M; Rosenkranz, A; Stadlbauer, V
Eine Nierentransplantation kann sich positiv auf die Funktion neutrophiler Granulozyten und den oxidativen Stress auswirken.
Transplant International, John Wiley & Sons, Ltd. 2014; 27(s4):1-27.-Austrotransplant; 15-17 Okt, 2014; Bad Ischl, Austria.
[Oral Communication]
FullText
Lemesch, S; Leber, B; Ribitsch, W; Schilcher, G; Horvath, A; Hafner-Giessauf, H; Spindelboeck, W; Pasterk, L; Marsche, G; Zettel, G; Tawdrous, M; Rosenkranz, A; Stadlbauer, V
KIDNEY TRANSPLANT MAY BE POSITIVE ON THE FUNCTION NEUTROPHILER GRANULOCYTES AND THE OXIDATIVE STRESS EFFECT
TRANSPL INT. 2014; 27: 6-6.-Austrotranspalnt; 15-17 Okt, 2014; Bad Ischl, Austria.
[Oral Communication]
Web of Science
Lemesch, S; Leber, B; Ribitsch, W; Schilcher, G; Horvath, A; Pasterk, L; Marsche, G; Spindelboeck, W; Hafner-Giessauf, H; Zettel, G; Tawdrous, M; A.R. Rosenkranz,AR; Stadlbauer, V
THE LEAKY GUT IN PATIENTS WITH RENAL DISEASE
Abstract. 2014; -ERA-EDTA Congress; SEP 6-9, 2014; Berlin, GERMANY.
[Poster]
Lemesch, S; Leber, B; Ribitsch, W; Schilcher, G; Horvath, A; Pasterk, L; Marsche, G; Spindelboeck, W; Hafner-Giessauf, H; Zettel, G; Tawdrous, M; Rosenkranz, A; Stadlbauer, V
Positiver Effekt der Nierentransplantation auf die Funktion neutrophiler Granulozyten und oxidativen Stress.
Austian Journal of Hypertension. 2014; 18(3):110-128.-Jahrestagung Nephrologie &
Hypertensiologie; 18-22 Sep, 2014; Baden, AUstria.
[Poster]
FullText
Lemesch, S; Leber, B; Ribitsch, W; Schilcher, G; Horvath, A; Pasterk, L; Marsche, G; Spindelboeck, W; Hafner-Giessauf, H; Zettel, G; Tawdrous, M; Rosenkranz, A; Stadlbauer, V
The leaky gut in patients with chronic kidney disease
UEG Journal. 2014; 2(suppl1):A132-A605.-UEGW; 18-22 Okt, 2014; Vienna, Austria.
[Poster]
FullText
Lemesch, S; Leber, B; Ribitsch, W; Schilcher, G; Horvath, A; Pasterk, L; Marsche, G; Spindelboeck, W; Hafner-Giessauf, H; Zettel, G; Tawdrous, M; Rosenkranz, A; Stadlbauer, V
The leaky gut in patients with renal disease
Abstract-USB Stick. 2014; -DGfN; 6-9 Sep, 2014; Berlin, Germany.
[Poster]
Lemesch ,S; Ribitsch, W; Leber, B; Schilcher, G; Horvath, A; Pasterk, L; Marsche, G; Spindelboeck, W; Hafner-Giessauf, H; Zettel, G; Tawdrous, M; A.R. Rosenkranz, AR; Stadlbauer, V;
POSTIVER EFFEKT DER NIERENTRANSPLANTATION AUF DIE FUNKTION NEUTROPHILER GRANULOZYTEN.
Jahrestagung Nephrologie und Hypertensiologie; 18.-20. Sept; Baden, AUSTRIA. 2014.
[Poster]
Marsche, G; Holzer, M; El-Gamal, D
The urea decomposition product cyanate promotes endothelial dysfunction
Symposium- Biomarker und Nierenerkrankungen
; JAN 17-18, 2014; Würzburg, GERMANY. 2014.
[Poster]
Marsche, G; Wolf, P; Holzer, M
Anti-psoriatic therapy recovers HDL composition and function independent of of serum HDL-cholesterol levels
7th IAS Workshop on HDL - Abstract Book. 2014; -7th IAS Workshop on HDL; MAR 24-26, 2014; Rom, Italy.
[Poster]
Opresnik, S; Rao, S.P; Hrzenjak, A; Hallström, S; Kozina, A; Sreckovic, I; Wadsack, Ch; Holzer, M; Marsche, G; Birner-Gruenberger, R; Stojakovic, T; Scharnagl, H; Frank, S
Endothelial Lipase Attenuates Vasorelaxing Capacity of HDL.
keine. 2014; -7th IAS Workshop on HDL; März 24-26, 2014; Rom, Italien.
[Poster]
Pasterk, L; Trieb, M; Curcic, S; Appierto, M; Schuligoi, R; Heinemann, A; Marsche, G
Uremia-induced oxidative modifications convert plasma albumin into platelet activators
Docteral Day ; DEC 10, 2014; Graz, AUSTRIA. 2014.
[Poster]
Pasterk, L; Trieb, M; Curcic, S; Appierto, M; Schuligoi, R; Heinemann, A; Marsche, G
Uremia-induced oxidative modifications convert plasma albumin into platelet activators.
Retreat DK-MOLIN; OCT 29-30; Seggau, Austria. 2014.
[Poster]
Pasterk, L; Trieb, M; Curcic, S; Appierto, M; Schuligoi, R; Heinemann, A; Marsche, G
Uremia-induced oxidative modifications convert plasma albumin into platelet activators
APHAR ; SEP 26-27; Innsbruck, AUSTRIA. 2014.
[Poster]
Sanja Curcic, Michael Holzer, Robert Frei, Lisa Pasterk, Akos Heinemann and Gunther Marsche
Secretory phospholipase A2 modified HDL shows potent anti-inflammatory effects on neutrophils
ZMF (Center for Medical Research) 10th Anniversary; JUL 17-18, 2014; Graz, AUSTRIA. 2014.
[Poster]
Sanja Curcic, Michael Holzer, Robert Frei, Lisa Pasterk, Akos Heinemann and Gunther Marsche
Secretory phospholipase A2 modified HDL fully suppresses neutrophil effector responses: Central role of palmitoyl-lysophosphatydilcholine
20th Scientific Symposium of the Austrian Pharmacological Society (APHAR); SEP 26-27; Innsbruck, Austria. 2014.
[Poster]
Sanja Curcic, Michael Holzer, Robert Frei, Lisa Pasterk, Akos Heinemann and Gunther Marsche
Secretory phospholipase A2 modified HDL fully suppresses neutrophil effector responses: Central role of palmitoyl-lysophosphatydilcholine
4th European Lipidomic Meeting; SEP 22-24; Graz, AUSTRIA. 2014.
[Poster]
Trieb, M; Horvath, A; Spindelböck, W; Stadlbauer, V; Stauber, RE; Pasterk, L; Marsche, G
Low HDL levels in cirrhotic patients are linked to severely impaired anti-inflammatory and endothelial regenerative activities of serum
Doctoral Day; DEC 10, 2014; Graz, AUSTRIA. 2014.
[Poster]
Trieb, M; Horvath, A; Spindelböck, W; Stadlbauer, V; Stauber, RE; Pasterk, L; Marsche, G
Low HDL levels in cirrhotic patients are linked to severely impaired anti-inflammatory and endothelial regenerative activities of serum
2nd Retreat, Doctoral College-Molecular Fundamentals of Inflammation; OKT 29-30, 2014; Seggau, AUSTRIA. 2014.
[Poster]
Trieb, M; Horvath, A; Stadlbauer, V; Pasterk, L; Marsche, G
Liver cirrhosis is associated with reduced anti-inflammatory capacity of serum: Central role of high-density lipoprotein
20th Scientific Symposium of the Austrian Pharmacological Society; SEP 26-27, 2014; Innsbruck, AUSTRIA. 2014.
[Poster]
Trieb, M; Horvath A; Stadlbauer V; Pasterk L; Marsche G
Liver cirrhosis is associated with reduced anti-inflammatory capacity of serum: Central role of high-density lipoprotein
Gordon Research Seminar; JUNE 14-15, 2014; Waterville Valley, USA. 2014.
[Poster]
Trieb M; Horvath A; Stadlbauer V; Pasterk L; Marsche G
Liver cirrhosis is associated with reduced anti-inflammatory capacity of serum: Central role of high-density lipoprotein
Gordon Research Conference; JUNE 15-20, 2014; Waterville Valley, USA. 2014.
[Poster]
Curcic, S; Holzer, M; Frank, S; Frei, R; Heinemann, A; Marsche, G;
Secretory phospholipase A2 drives reprogramming of neutrophils
Doctoral Day 2013; DEZ 9, 2013; Graz, AUSTRIA. 2013.
[Poster]
Curcic, S; Holzer, M; Heinemann, A; Marsche, G
Acute-phase secretory phospholipases have a potent antiinflammatory activity.
Joint Meeting of the Austrian Neuroscience Association (13th ANA Meeting) and the Austrian Pharmacological Society (19th Scientific Symposium of APHAR); SEP 16-19, 2013; Vienna, AUSTRIA. 2013.
[Oral Communication]
Holzer, M; Wolf, P; Inzinger, M; Trieb, M; Curcic, S; Pasterk, L; Weger, W; Heinemann, A; Marsche, G.
Anti-psoriatic therapy recovers high-density lipoprotein composition and function
Intrinsic Activity. 2013; 1(1):-Joint Meeting of the Austrian Neuroscience Association (13th ANA Meeting) and the Austrian Pharmacological Society (19th Scientific Symposium of APHAR) ; SEP 16-19, 2013; Vienna, AUSTRIA.
[Poster]
FullText
Kober, AC; Chirackal Manavalan, AP; Marsche, G; Holzer, M; Grünberger, RM; Kostner, G; Holmer, A; Dahlbäck, B; Panzenboeck, U
ATP-binding Cassette Transporter G1 and Apolipoprotein M Are 'Novel Players' in Cholesterol Transport at the Blood-brain Barrier
11th International Conference on Alzheimers and Parkinsons Diseases and related neurological disorders; MARCH 5-10, 2013; Florence, Italy. 2013.
[Poster]
Kopecky, C; Haidinger, M; Kaltenecker, C; Antlanger, M; Marsche, G; Holzer, M; Kovarik, J; Werzowa, J; Hecking, M; Saemann, M
Dysfunctional High-Density Lipoprotein as a Novel Cardiovascular Risk Factor after Kidney Transplantation.
Nephrology Dialysis Transplantation Supplement. 2013; 13: 413-413.-50th ERA-EDTA Congress; MAY 18-21, 2013; Istanbul.
[Poster]
Web of Science
Kopecky, C; Haidinger, M; Kaltenecker, C; Antlanger, M; Marsche, G; Holzer, M; Kovarik, J; Werzowa, J; Hecking, M; Saemann, M.
Dysfunctional High-Density Lipoprotein as a Novel Cardiovascular Risk Factor after Kidney Transplantation
AMERICAN JOURNAL OF TRANSPLANTATION Supplement. 2013; -American Transplant Congress; MAY 18-22; Seattle, USA.
[Poster]
Kopecky, C; Haidinger, M; Kaltenecker, C; Antlanger, M; Marsche, G; Holzer, M; Kovarik, J; Werzowa, J; Hecking, M; Saemann, MD
THE MOLECULAR COMPOSITION AND FUNCTION OF HIGH-DENSITY LIPOPROTEIN IS UNIQUELY ALTERED AFTER KIDNEY TRANSPLANTATION
TRANSPL INT. . 2013; 26: 242-242.
[Poster]
Web of Science
Kopecky, C; Haidinger, M; Kaltenecker, C; Antlanger, M; Marsche, G; Holzer, M; Kovarik, J; Werzowa, J; Hecking, M; Säemann, MD
DYSFUNCTIONAL HIGH-DENSITY LIPOPROTEIN AS A NOVEL CARDIOVASCULAR RISK FACTOR AFTER KIDNEY TRANSPLANTATION
ATHEROSCLEROSIS SUPPLEMENTS. 2013. 2013; -European Atherosclerosis Society Congress; JUN 2-5,2013; Lyon, FRANCE.
[Poster]
Kopecky, C; Haidinger, M; Kaltenecker, C; Birner-Grünberger, R; Marsche, G; Holzer, M; Saemann, M
The molecular composition and function of high-density lipoprotein is uniquely altered after kidney transplantation
9th YSA PhD-Symposium Abstract_Book_2013. 2013; -9th YSA PhD-Symposium; JUN 19-20, 2013; Vienna, AUSTRIA.
[Poster]
Kopecky, CM; Haidinger, M; Kaltenecker, C; Antlanger, M; Marsche, G; Holzer, M; Kovarik, J; Werzowa, J; Hecking, M; Saemann, MD;
DYSFUNCTIONAL HIGH-DENSITY LIPOPROTEIN AS A NOVEL CARDIOVASCULAR RISK FACTOR AFTER KIDNEY TRANSPLANTATION.
NEPHROL DIALYSIS TRANSPLANT. 2013; 28: 281-282.-50th European-Renal-Association - European-Dialysis-and-Transplant-Association Congress; MAY 18-21, 2013; Istanbul, TURKEY.
[Poster]
Web of Science
Marsche, G; Wolf, P; Holzer, M
PSORIASIS ALTERS HDL COMPOSITION AND FUNCTION
ATHEROSCLEROSIS SUPPLEMENTS. 2013; -European Atherosclerosis Society Congress; JUN 2-5,2013; Lyon, FRANCE.
[Poster]
Opresnik, S; Rao, SP; Hrzenjak, A; Hallström, S; Kozina, A; Sreckovic, I; Wadsack, Ch; Holzer, M; Marsche, G; Birner-Grünberger, R; Stojakovic, T; Scharnagl, H; Frank, S
Endothelial lipase attenuates vasorelaxing capacity of HDL
43. Jahrestagung des Arbeitskreises ''Klinischer Lipidstoffwechsel'' Maikammer 2013; NOV 28-30, 2013; Maikammer, Deutschland. 2013.
[Oral Communication]
Pasterk, L; Trieb, M; Schilcher, G; Rosenkranz, AR; Heinemann, A; Marsche, G
The Effect of Oxidized Plasma Albumin on Platelet Function
Doctoral Day 2013; DEC 9, 2013; Graz, AUSTRIA. 2013.
[Oral Communication]
Pasterk, L; Trieb, M; Schilcher, G; Rosenkranz, AR; Heinemann, A; Marsche, G
The Effect of Oxidized Plasma Albumin on Platelet Function
first retreat, DK-MOLIN; NOV 6-7, 2013; Seggau, AUSTRIA. 2013.
[Oral Communication]
Trieb, M; Horvath, A; Stadlbauer-Köllner, V; Pasterk, L; Holzer, M; Marsche, G
The anti-inflammatory capacity of serum is severely impaired in patients with liver disease and causally linked to a defective HDL metabolism.
Doctoral Day; DEZ 9, 2013; Graz, AUSTRIA. 2013.
[Poster]
Trieb, M; Horvath, A; Stadlbauer-Köllner, V; Pasterk, L; Holzer, M; Marsche, G
The anti-inflammatory capacity of serum is severely impaired in patients with liver disease and causally linked to a defective HDL metabolism.
1st Retreat, Doctoral College-Molecular Fundamentals of Inflammation; NOV 6-7, 2013; Seggau, AUSTRIA. 2013.
[Oral Communication]
Binder, V; Holzer, M; El-Gamal, D; Dirnberger, S; Marsche, G
Uremic albumin blocks reverse cholesterol transfer: Role of lysine modifications.
EAS 2012 Abstract Book . 2012; -80th European Atherosclerosis Society Congress; MAY 25-28, 2012; Milano, Italy.
[Poster]
FullText
Binder, V; Holzer, M; El-Gamal, D; Dirnberger, S; Marsche, G;
HOCl-oxidation converts plasma albumin into an irreversible HDL-receptor antagonist.
Doctoral Day 2012; DEC 7, 2012; Graz, Austria. 2012.
[Poster]
Binder, V; Ljubojevic, S; Holzer, M; El-Gamal, D; Dirnberger, S; Pieske, B; Marsche, G;
HOCl-oxidation converts plasma albumin into an irreversible HDL-receptor antagonist
18th Scientific Symposium of the Austrian Pharmacological Society (APHAR); SEPT 20-21, 2012; Graz, Austria. 2012.
[Poster]
Curcic, S;Holzer, M; Schilcher, G; Rosenkranz, A; Stojakovic,T;Heinemann, A; Marsche, G;
Chronic kidney disease alters anti-inflammatory properties of HDL.
Doctoral Day 2012; Dec 7, 2012; Graz, AUSTRIA. 2012.
[Oral Communication]
El-Gamal, D; Holzer, M; Gauster, M; Binder, V; Heinemann, A; Marsche, G
Cyanate triggers vascular endothelial inflammation
Keystone Symposium Conference on Molecular Basis of Vascular Inflammation and Atherosclerosis (C7). 2012; -Keystone Symposium ; MAR 25-30, 2012; Big Sky, Montana, USA.
[Poster]
El-Gamal, D;Holzer, M; Gauster, M; Binder, V; and Marsche, G:
Cyanate, a novel inflammatory trigger, induces endothelial dysfunction.
18th Scientific Symposium of the Austrian Pharmacological Society (APHAR); SEPT 20-21, 2012; Graz, Austria. 2012.
[Poster]
Holzer, M; Birner-Grünberger, R; Stojakoviæ, T; El-Gamal, D; Binder, V; Wadsack, C; Heinemann, A; Marsche, G.
Uremia alters HDL composition and cholesterol efflux capacity
BMC Pharmacology & Toxicology Supplements. 2012; 13(1):-18th Scientific Symposium of the Austrian Pharmacological Society (APHAR) ; SEP 20-21, 2012; Graz, Austria.
[Oral Communication]
FullText
Holzer, M; Curcic, S; El-Gamal, D; Binder, V; Schilcher, G; Rosenkranz, A; Marsche, G
Peritoneal dialysis and hemodialysis differentially modulate HDL composition and function
ATHEROSCLEROSIS SUPPLEMENTS. 2012; -European Atherosclerosis Society Congress; MAI 25-28, 2012; MAILAND.
[Poster]
FullText
Kargl, J; Haybaeck, J; Stančić, AA; Marsche, G; Heinemann, A; Schicho, R;
The atypical cannabinoid O-1602 shows antitumorigenic effects in colon cancer cells and reduces tumor growth in a colitis-associated colon cancer model
BMC Pharmacology and Toxicology 2012, 13(Suppl 1): A23 . 2012; 13: - 18th Scientific Symposium of the Austrian Pharmacological Society (APHAR); Sept 20-21, 2012; Graz, Austria.
[Oral Communication]
FullText
Manavalan, APC, Kober A, Schweinzer C, Scholler M, Becker T, Hasslitzer K, Marsche G, Holzer M, Kostner G, Birner-Gruenberger R, Stefulj J, Jauhiainen M, Panzenboeck U
Liver X receptor activation in cerebrovascular endothelial cells regulates genes involved in HDL metabolism at the blood brain barrier
Proceedings of the 4th International Graz Symposium on Lipid and Membrane Biology. 2012; -4th International Symposium on Lipid and Membrane Biology; Mar 8-10; Graz, Austria.
[Poster]
FullText
Marsche,G; El-Gamal,D; Binder,V; Curcic,S; Holzer,M;
Myeloperoxidase favors lipoprotein carbamylation: Novel pathways generating dysfunctional high-density lipoprotein
Meeting Abstract; ATHEROSCLEROSIS SUPPLEMENTS. 2012; -80th European Atherosclerosis Society Congress; MAI 28-28,2012; Milan, ITALY.
[Oral Communication]
Philipose, S; Konya, V; Lazarevic, M; Pasterk, L; Marsche, G; Frank, S; Peskar, BA; Heinemann, A; Schuligoi, R;
Laropiprant Attenuates EP3 and TP Prostanoid Receptor-Mediated Thrombus Formation.
BMC Pharmacology and Toxicology 2012
18th Scientific Symposium of the Austrian
Pharmacological Society (APHAR). 2012; -Austrian Pharmacological Society (APHAR) Joint Meeting with the Croatian, Serbian and Slovenian Pharmacological Societies; SEP 20-21,2012; Graz, Austria.
[Poster]
FullText
Binder, V; Holzer, M; El-Gamal, D; Dirnberger, S; and Marsche, G
Uremic albumin blocks reverse cholesterol transfer: role of lysine modifications
Meeting abstract from 17th Scientific Symposium of the Austrian Pharmacological Society (APHAR). . 2011; 11(S2):-17th Scientific Symposium of the Austrian Pharmacological Society (APHAR)
Joint meeting with the Hungarian Society of Experimental and Clinical Pharmacology (MFT); Sept 29-30, 2011; Innsbruck, AUSTRIA.
[Poster]
FullText
Binder, V; Holzer, M; El-Gamal, D; Dirnberger, S; and Marsche, G;
Uremic albumin blocks reverse cholesterol transfer: Role of lysine modifications
Doctoral Day 2011; NOV 4, 2011; Graz, AUSTRIA. 2011.
[Poster]
El-Gamal, D; Holzer, M; Binder, V; Dirnberger, S; Heinemann, A; Marsche, G
Urea induces intercellular adhesion molecule-1 expression
Meeting abstract in the 17th Scientific Symposium of the Austrian Pharmacological Society (APHAR).. 2011; 11(S 2):-17th Scientific Symposium of the Austrian Pharmacological Society (APHAR) Joint Meeting with the Hungarian Society for Experimental and Clinical Pharmacology (MFT); Sept 29-30, 2011; Innsbruck, Austria.
[Oral Communication]
FullText
El-Gamal, D; Holzer, M; Gauster, M; Schicho, R ; Binder, V; Heinemann, A; Marsche, G
Cyanate is a novel inducer of endothelial intercellular adhesion molecule-1 (ICAM-1)
Doctoral Day; 4 Nov, 2011; Graz, Austria. 2011.
[Poster]
Holzer, M; Birner-Gruenberger, R; Binder, V; El-Gamal, D; Marsche, G
PROTEOMIC ALTERATIONS OF HDL FROM HEMODIALYSIS PATIENTS ARE ASSOCIATED WITH IMPAIRED CHOLESTEROL EFFLUX CAPACITY
ATHEROSCLEROSIS SUPP. 2011; 12(1):39-39.-79th Congress of the European-Atherosclerosis-Society (EAS); JUN 26-29, 2011; Gothenburg, SWEDEN.
Doi: 10.1016/S1567-5688(11)70174-X
[Poster]
Web of Science
FullText
FullText_MUG
Holzer, M; Birner-Gruenberger, R: El-Gamal, D; Binder, V; Marsche, G
HDL from hemodialysis patients carries a unique protein and lipid cargo associated with impaired cholesterol efflux capacity
Gordon Research Conference on Atherosclerosis; JUN 19-24, 2011; Newport, USA. 2011.
[Poster]
Holzer, M; Birner-Gruenberger, R: El-Gamal, D; Binder, V; Marsche, G
HDL from hemodialysis patients carries a unique protein and lipid cargo associated with impaired cholesterol efflux capacity
EAS 2011 - Congress Abstracts. 2011; -79th European Atherosclerosis Society Congress; JUN 26-29; Gothenborg, SWEDEN.
[Poster]
Holzer, M; Birner-Gruenberger, R; Stojakovic, T; El-Gamal, D;
Binder, V; Wadsack, C; Heinemann, A; Marsche, G
Uremia Alters HDL Composition and Function
Doctoral Day 2011; NOV 4, 2011; GRAZ, AUSTRIA. 2011.
[Poster]
Holzer, M; Gauster, M; Wadsack, C; El-Gamal, D; Binder, V; Heinemann, A; Marsche, G
Protein carbamylation renders HDL dysfunctional
7th Human Peroxidase Meeting; MAY 22-25. 2011; Brussel, Belgium. 2011.
[Oral Communication]
Ljubojevic, S; Sedej, S; Holzer, M; Marsche, G; Marijanski, V; Kockskaemper, J; Pieske, B
Subcellular localization and expression levels of TRPC3, ORAI1, and STIM1 in normal and hypertrophied mouse heart
EUR HEART J SUPPL. 2011; 13(A):A37-A37.-10th International Conference of Non-Invasive Cardiovascular Imaging; MAY 15-18, 2011; Amsterdam, NETHERLANDS.
[Oral Communication]
Web of Science
Ljubojevic, S; Sedej, S; Holzer, M; Marsche, G; Marijanski, V; Kockskämper, J; Pieske, B
Expression and Subcellular Localization of TRPC3, Orai1, and STIM1 after Pressure Overload-Induced Hypertrophy in Adult Cardiac Myocytes
Biophysical Journal, Suppl.
2011; 100(3):85a--55. Biophysical Society Meeting; MAR 4-9, 2011; Baltimore, USA.
[Poster]
Marsche, G; Gauster, M; Holzer, M
PROTEIN CARBAMYLATION RENDERS HIGH-DENSITY LIPOPROTEIN DYSFUNCTIONAL
ATHEROSCLEROSIS SUPP. 2011; 12(1):39-39.-79th Congress of the European-Atherosclerosis-Society (EAS); JUN 26-29, 2011; Gothenburg, SWEDEN.
Doi: 10.1016/S1567-5688(11)70178-7
[Poster]
Web of Science
FullText
FullText_MUG
Schweinzer, C; Kober, A; Etschmaier, K; Scholler, M; Holzer, M;Marsche, G;
Sattler, W; Panzenboeck, U
Liver X receptor agonists and altered cellular cholesterol metabolism modulate APP expression in cerebromicrovascular endothelial cells.
18th ANNUAL MEETING - AAS of the Austrian Atherosclerosis Society; MAY 6-7, 2011; St. Gilgen, AUSTRIA. 2011.
[Oral Communication]
Sreckovic, I; Birner-Gruenberger, R; Philipose, S; Holzer, M; Marsche, G; Desoye, G; Lang, U; Wadsack, C
APOLIPOPROTEINS (APO) ACCOUNTS FOR THE ANTI-INFLAMMATORY FUNCTION OF FETAL HDL
PLACENTA. 2011; 32(9):A112-A112.-Meeting of the International-Federation-of-Placenta-Associations (IFPA); SEP 14-17, 2011; Geilo, NORWAY.
[Poster]
Web of Science
Becker, TM; Stefulj, J; Hirschmugl, B; Schweinzer, C; Scholler, M; Marsche, G; Lang, I; Lang, U; Desoye, G; Wadsack, C; Panzenboeck, U
Cholesterol enters the fetal circulation in humans via ATP-binding cassette transporters A1 and G1.
2nd ÖGMBT Annual Meeting 2010 together with the Austrian Biophysical Society Molecular and Applied Biosciences Austria 2010. Abstractbook S.108, P140; Sep 27-29, 2010; Vienna, AUSTRIA. 2010.
[Poster]
Binder, V; Holzer, M; El-Gamal, D; Dirnberger, S; Marsche, G
Lysine Oxidation is required for high affinity binding of albumin to the HDL receptor SR-BI
Joint ZMF and Doctoral Days 2010; Nov 5-6, 2010; Graz, Austria. 2010.
[Poster]
Birner-Gruenberger, R; Marsche, G; Moertl, M; Desoye, G; Lang, U; Wadsack, C
Divergence of Maternal and Fetal High Density Lipoproteins
Triglycerides and Triglyceride-Rich Particles in Health and Disease ; JAN 9-13, 2010; Big Sky, Montana, USA. 2010.
[Poster]
El-Gamal, D; Holzer, M; Binder, V; Dirnberger, S; Wadsack, C; Heinemann, A; Marsche, G
Urea Induces Intercellular Adhesion Molecule-1 Expression and Inhibits Endothelial Nitric Oxide Synthase in Human Coronary Artery Endothelial Cells.
Granted Best PhD Poster Award ''Posterpreis PhD''
Joint ZMF and Doctoral Days 2010; NOV 5-6, 2010; Graz. 2010.
[Poster]
Holzer, M; Gauster, M; Binder, V; El-Gamal, D; Wadsack, C; Heinemann, A; Marsche, G
Cyanate transforms HDL into a pro-atherogenic lipoprotein
APHAR 2010; NOV 26-27; VIENNA. 2010.
[Poster]
Holzer, M; Gauster, M; Wadsack, C; Fauler, F; Heinemann, A; Marsche, G
Cyanate transforms HDL into a pro-atherogenic lipoprotein in human atherosclerotic lesions
European Society of Cardiology Congress 2010; AUGUST 28 - SEPTEMBER 1; STOCKHOLM. 2010.
[Poster]
Holzer, M; Gauster, M; Wadsack, C; Fauler, G; Marsche, G
Cyanate transforms HDL into a pro-atherogenic lipoprotein in human atherosclerotic lesions
JOINT ZMF & DOCTORAL DAY 2010; NOV 5-6; GRAZ, AUSTRIA. 2010.
[Oral Communication]
Holzer, M; Gauster, M; Wadsack, C; Marsche, G
Cyanate selectively disrupts anti-atherogenic activities of high-density lipoprotein in human atherosclerotic lesions
EUR HEART J. 2010; 31: 250-250.
[Poster]
Web of Science
Schweinzer, C; Kober, A; Scholler, M; Etschmaier, K; Holzer, M; Marsche, G; Sattler, W; Panzenböck, U
Amyloid Precursor Protein Metabolism at the Blood-Brain Barrier is Influenced by Cholesterol and Liver X Receptor Ligands
ÖGMBT Annual Meeting 2010; SEP, 27-29, 2010; Vienna, AUSTRIA. 2010.
[Poster]
Becker, T; Stefulj, J; Hirschmugl, B; Schweinzer, C; Marsche, G; Lang, I; Desoye, G; Wadsack, C; Panzenboeck, U
Cholesterol enters the fetal circulation in humans via ATP-binding cassette transporters A1 and G1.
7th Euro Fed Lipid Congress. Lipids, Fats and Oils - From Knowledge to Application; OCT 18-22; Graz, AUSTRIA. 2009.
[Poster]
Birner-Gruenberger, R; Marsche, G; Moertl, M; Desoye, G; Lang, U; Wadsack, C
Shotgun proteomics implicates different protein composition of maternal and fetal high density lipoprotein
1st Styrian Conference on Lipid Mass Spec; OCT 21-22, 2009; Graz, AUSTRIA. 2009.
[Poster]
Birner-Grünberger, R; Marsche, G; Desoye, G; Lang, U; Wadsack, C
Shotgun Proteomics of fetal HDL implicates role in Gestational Diabetes
Abstractband. 2009; -41th Annual Meeting of the Diabetic Pregnancy Study Group (DPSG); September,2009; Rom,Italien.
[Poster]
Birner-Grünberger, R; Marsche, G; Mörtl, M; Desoye, G; Lang, U; Wadsack, C
Shotgun Proteomics Implicates Different Protein Composition of Maternal - and Fetal HDL
Konferenzband2009; -Joint ZMF & Doctoral Days 2009; Nov,2009; Graz, Austria.
[Poster]
Cvirn, G; Ferstl, U; Gütl, S; Janschitz, M; Juergens, G; Kager, G; Koestenberger, M; Marsche, G; Tafeit, E
Abgeschlossene, aktuelle und geplante Forschungstätigkeiten der Arbeitsgruppe Blutgerinnung
Zentrumsmeeting, Zentrum für Physiologische Medizin; JUL 8, 2009; Graz, AUSTRIA. 2009.
[Poster]
Holzer, M; Gauster, M; Birner-Gruenberger, R; Marsche, G
Carbamylation Impairs the Functional Integrity of High-Density Lipoprotein (HDL).
7th Euro Fed Lipid Congress. Lipids, Fats and Oils - From Knowledge to Application; OCT 18-22, 2009; Graz, AUSTRIA. 2009.
[Poster]
Holzer, M; Gauster, M; Birner-Gruenberger, R; Marsche, G
CARBAMYLATION RENDERS HIGH-DENSITY LIPOPROTEIN DYSFUNCTIONAL.
International Congress on Coronary Artery Disease, ICCAD; OKT 11-14, 2009; Prague, Czech Republic. 2009.
[Poster]
Holzer, M; Gauster, M;Birner-Grünberger, R; Marsche, G;
The effect of carbamylation on the functionality of high-density lipoprotein
15th Scientific Symposium of the Austrian Pharmacological Society (APHAR) ; NOV 19-21, 2009; Graz, AUSTRIA. 2009.
[Poster]
FullText
Marsche, G; Frank, S; Hrzenjak, A; Holzer, M; Heinemann, A; Öttl, K
Advanced oxidation protein products are antagonists of the HDL receptor SR-BI
Circulation Research2009; 104(6):750-757.-15th Scientific Symposium of the Austrian Pharmacological Society (APHAR) ; NOV 19-21, 2009; Graz, Austria. (ISBN: 0009-7330 )
[Oral Communication]
Marsche, G; Holzer, M; Wadsack, C; Frank, S; Heinemann, A
ADVANCED OXIDATION PROTEIN PRODUCTS ARE PROINFLAMMATORY MEDIATORS THAT DIRECTLY IMPAIR HDL METABOLISM.
International Congress on Coronary Artery Disease, ICCAD; OCT 11-14, 2009; Prague, Czech Republic. 2009.
[Poster]
FullText
Marsche, G; Holzer, M; Wadsack, C; Heinemann, A
Advanced Oxidation Protein Products Block the HDL Receptor SR-BI.
7th Euro Fed Lipid Congress. Lipids, Fats and Oils - From Knowledge to Application; OCT 18-22, 2009; Graz, AUSTRIA. 2009.
[Poster]
FullText
Oettl, K; Greilberger, J; Lamprecht, M; Stadlbauer, V; Stauber, RE; Frank, S; Marsche, G
Oxidative Modified Human Serum Albumin: New Aspects of a well Known Molecule.
Pteridines. 2009; 20: 28-29.-International Winter-Workshop on Clinical, Chemical and Biochemical Aspects of Pteridines; MAR 1-8, 2009; St.Christoph, AUSTRIA.
[Oral Communication]
Schweinzer, C; Becker, T; Scholler, M; Etschmaier, K; Holzer, M; Marsche, G; Birner-Gruenberger, R; Sattler, W; Panzenboeck, U
Amyloid Precursor Protein Metabolism at the Blood-Brain Barrier is influenced by Cholesterol and Liver X Receptor Ligands.
7th Euro Fed Lipid Congress. Lipids, Fats and Oils - From Knowledge to Application; OCT 18-22; Graz, AUSTRIA. 2009.
[Poster]
FullText
Becker, T; Schweinzer, C; Stefulj, J; Hirschmugl, B; Marsche, G; Lang, U; Desoye, G; Wadsack, C and Panzenböck, U
ATP-binding cassette transporters A1 and G1 promote cholesterol efflux from fetal endothelial cells of human placenta
Joint Meeting Life Science 2008; September 22nd -24th, 2008 ; Graz, Austria. 2008.
[Poster]
Becker, T; Schweinzer, C; Stefulj, J; Hirschmugl, B; Marsche, G; Lang, U; Desoye, G; Wadsack, C and Panzenböck, U
ATP-binding cassette transporters A1 and G1 promote cholesterol efflux from
fetal endothelial cells of human placenta
SFB Annual Symposium: Transmembrane Transporters in Health and Disease; September 26th - 27 th, 2008; Vienna, Austria. 2008.
[Poster]
Panzenboeck, U; Becker, T; Stefulj, J; Hirschmugl, B; Schweinzer, C; Marsche, G; Lang, U; Desoye, G; Wadsack C
ATP-binding cassette transporters A1 and G1 promote cholesterol efflux from fetal endothelial cells of human placenta.
Placenta. 2008; 29(8):A11--European Placenta Group Meeting
14th IFPA Congress; SEP 10-13; Seggau Castle Austria.
[Poster]
Web of Science
Stefulj, J; Becker,T; Hirschmugl,B; Schweinzer, C; Hasslitzer, K; Marsche, G; Desoye,G; Wadsack,C and Panzenboeck, U
ABCA1 and ABCG1 are operative in fetal endothelial cells of the human placenta
2nd International Graz Symposium on Lipid and Membrane Biology: Focus on Lipotoxicity; March 13.-15, 2008; Graz, Austria. 2008.
[Poster]
Marsche, G; Semlitsch, M; Frank, S; Sattler, W; Malle, E
Hypochlorite-modified albumin promotes RAGE-dependent signaling
The 5th International Meeting on Human Peroxidases; FEB 20-23, 2007; Akaroa, New Zealand. 2007.
[Oral Communication]
Marsche, G; Weigle, B; Sattler, W; Malle, E
The soluble Form of the Receptor for Advanced Glycation End Products (sRAGE) blocks Scavenger Receptor CD36-mediated uptake of Hypochlorite-modified Low-density lipoprotein
30th Annual Meeting of the Lipoprotein Club; SEP 3-6, 2007; Tutzing, Germany. 2007.
[Oral Communication]
Bernhart, E; Panzenboeck, U; Marsche, G; Sattler, W; Malle, E
Hypochlorite-modified high density lipoprotein compromises blood-brain barrier function in vitro
SFB Evaluation Hearing; OKT 17, 2006; Vienna, Austria. 2006.
[Poster]
Marsche, G; Malle, E; Rechberger, G; Zechner, R; Sattler, W
Hypochlorite modified plasmalogen and sphingomyelin modulate neuronal protein expression and attenuate cell viability
SFB-Hearing; OKT 17, 2006; Vienna, Austria. 2006.
[Poster]
Schaefer, L; Babelova, A; Kiss, E; Hausser, H; Marsche, G; Young, M; Gotte, M; Malle, E; Schaefer, RM; Grone, HJ
The matrix component biglycan is proinflammatory and signals through toll-like receptor-4 and-2 in macrophages
NAUNYN-SCHMIED ARCH PHARMACOL. 2006; 372: 21-21.
[Oral Communication]
Web of Science
Marsche, G; Heller, R; Fauler, G; Kovacevic, A; Nuszkowski, A; Greier, W; Sattler, W; Malle, E
2-Chlorohexadecanal, deriverd from hypochlorite-modified high-density lipoprotein-associated plasmalogen is a natural inhibitor of endothelial nitric oxide biosynthesis
13. Atherosklerose-Symposium Erfurt; JUN 17-18, 2005; Erfurt, GERMANY. 2005.
[Oral Communication]
Marsche, G; Panzenboeck, U; Bernhart, E;, Semlitsch, M;Hammer, A;Groschner, K;Sattler, W; Malle, E;
Myeloperoxidase-generated products HOCl and HOCl-oxidized high-density lipoprotein disrupt blood-brain barrier tight junctions
FWF Evaluation Hearing; JUL 21, 2005; Graz, Austria. 2005.
[Poster]
Semlitsch, M;Marsche, G; Sundl, M; Hammer, A; Sattler, W; Mayer, B;
Schmidt, K; Malle, E
RAGE as a canditate receptor for hypochlorite-modified lipoproteins
FWF Evaluation Hearing; JUL 21, 2005; Graz, Austria. 2005.
[Poster]
Malle , E; Sattler, W; Marsche, G
Class B scavenger receptors CD36 and SR-BI are receptors for hypochlorite-modified low-density lipoprotein
XIV Lipid Meeting Leipzig; DEZ 5-7, 2003; Leipzig, Germany. 2003.
[Oral Communication]
Marsche, G; Levak-Frank S, Quehenberger, O; Heller, R; Sattler, W; Malle, E
Identification of SR-BI and LOX-1 as receptors for hypochlorite-modified high-density lipoprotein on human umbilical venous endothelial cells
10. Atherosklerose Symposium; JUN 21-22, 2002; Erfurt, GERMANY. 2002.
[Oral Communication]
Marsche, G; Sattler, W; Malle, E;
SR-BI is synthesized by human venous endothelial cells and mediates interaction with hypochlorite-modified high-density lipoprotein
XIII Lipid Meeting Leipzig; SEP 30 - October 2, 2002; Leipzig, Germany. 2002.
[Oral Communication]
Nuszkowski, A; Graebner, R; Marsche, G; Unbehaun, A; Morgenstern, E; Malle, E; Heller, R
Hypochlorite-modified low-density lipoprotein inhibits nitric oxide synthesis in endothelial cells via an intracellular dislocalization of nitric oxide synthase
Second International Conference of the Nitric Oxide Society; JUN 16-20, 2002; Prague, Czech Republic. 2002.
[Oral Communication]
Artl, A; Marsche, G; Pussinen, P; Knipping, G; Sattler, W; Malle, E
Impaired capacity of serum amyloid ASAA-enriched acute-phase high-density lipoprotein to deliver cholesteryl ester to human hepatoma cells. A possible role of scavenger receptor class B, type I?
AMYLOID 2001 8: 19-19.
Web of Science
Malle, E; Marsche, G; Sattler, W; Artl, A
Selective uptake of cholesteryl ester from native and acute-phase (SAA-enriched) HDL by hepatoma cells
23. Annual Conference, European Lipoprotein Club; SEP 11-14, 2000; Tutzing, GERMANY. 2000.
[Oral Communication]
Marsche, G; Levac-Frank, S; Heller, R; Quehenberger, O; Sattler, W; Malle, E
Interaction of HOCl-modified HDL with endothelial cells
Jahrestagung der Österreichischen Atherosklerosegesellschaft; MAI 5-6, 2000; St. Wolfgang, AUSTRIA. 2000.
[Oral Communication]
Artl, A; Marsche, G; Quehenberger, O; Herz, R; Sattler, W; Malle, E
Selective uptake of HDL-associated cholesteryl-esters by Cla-1 overexpressing HEK 293 Cells: Role of Serum Amyloid A (SAA)
Jahrestagung der Österreichischen Atherosklerosegesellschaft (AAS); APR 23-24, 1999; Werfenweng, AUSTRIA. 1999.
[Poster]
Marsche, G; Artl, A; Wadsack, C; Malle, E
Binding properties, selective uptake of cholesterol esters and cholesterol efflux properties of native and hypochlorite (HOCl)-modified HDL3 with endothelial cells
Jahrestagung der Österreichischen Atherosklerosegesellschaft (AAS); APR 23-24, 1999; Werfenweng, AUSTRIA. 1999.
[Poster]
Marsche, G; Sattler, W; Malle, E
Interaction of native and hypochlorite-modified high-density-lipoproteins with endothelial cells
8. Atherosklerose-Symposium ; JUN 18-19, 1999; Erfurt, GERMANY. 1999.
[Oral Communication]